MarketCapExport financials
Hims & Hers Health (HIMS)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Hims & Hers Health Balance Sheet 2025-2011 | HIMS
Brief overview of Hims & Hers Health's assets and capital
The comparison uses five available annual reports from the 2021–2025 interval.
Assets reached $2.2 billion, compared with $420.6 million at the beginning. Growth of +412.3% and CAGR near 50.4% show active expansion.
Liability growth of +1,777.2% exceeded asset growth of +412.3%, increasing reliance on outside funding.
Shareholders' equity accounts for 25.1% of assets, previously 79.6%. Dependence on liabilities is moderate.
Net debt reached $748.8 million, equal to 1.38x of equity. The debt profile is moderately stretched.
The cash reserve occupies 10.6% of the balance sheet, previously 17.1%. It is one marker of short-term resilience.
Retained earnings are negative at -$113.8 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Conclusion
The balance sheet gives no single signal for Hims & Hers Health: some indicators are sound, while leverage or capitalization needs attention.
Annual Balance Sheet Hims & Hers Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
749 M | -209 M | -86.7 M | -41.5 M | -66.3 M | - | -1.51 M | - | - | - | - | - | - | - | - |
Long Term Debt |
973 M | 9.46 M | 8.67 M | 3.65 M | 4.12 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
4.84 M | 1.89 M | 1.28 M | 1.66 M | 1.36 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 17.5 M | - | - | - | - | - | - | - | - |
Total Current Liabilities |
404 M | 221 M | 88.5 M | 47.9 M | 79.2 M | 15.2 M | 979 K | - | - | - | - | - | - | - | - |
Total Liabilities |
1.61 B | 231 M | 97.2 M | 54.6 M | 86 M | 12.1 M | 18.5 M | - | - | - | - | - | - | - | - |
Deferred Revenue |
127 M | 75.3 M | 7.73 M | 1.47 M | 3.19 M | 1.27 M | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-114 M | -242 M | -368 M | -345 M | -279 M | -1.9 M | 5 M | - | - | - | - | - | - | - | - |
Total Assets |
2.15 B | 708 M | 441 M | 366 M | 421 M | 206 M | 205 M | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
229 M | 221 M | 96.7 M | 46.8 M | 71.8 M | 27.3 M | 1.51 M | 41.6 M | - | - | - | - | - | - | - |
Book Value |
541 M | 477 M | 344 M | 312 M | 335 M | 194 M | 186 M | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
541 M | 477 M | 344 M | 312 M | 335 M | -147 M | -140 M | -71.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Hims & Hers Health
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
143 M | 974 M | 9.46 M | 971 M | 969 M | 59.6 M | 8.67 M | 9.56 M | 9.84 M | 10.3 M | 3.65 M | 2.75 M | 3.25 M | 3.22 M | 3.65 M | 4.08 M | 3.4 M | 3.76 M | 4.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.61 B | 1.82 B | 231 M | 1.65 B | 1.31 B | 342 M | 97.2 M | 162 M | 119 M | 104 M | 54.6 M | 85.3 M | 69.8 M | 63.6 M | 54.6 M | 71.9 M | 60.9 M | 54.3 M | 86 M | 64.9 M | 54.6 M | 53.4 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 20.6 M | 8.17 M | 8.17 M | 8.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
127 M | 165 M | 75.3 M | 118 M | 98.4 M | 111 M | 7.73 M | 32.2 M | 21 M | 13.7 M | 1.47 M | 4.39 M | 2.06 M | 2.87 M | 1.47 M | 2.12 M | 2.34 M | 1.14 M | 3.19 M | 1.99 M | 1.02 M | 624 K | 1.27 M | 1.27 M | 1.27 M | 1.27 M | 753 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-114 M | -206 M | -242 M | -134 M | -150 M | -193 M | -368 M | -268 M | -344 M | -357 M | -345 M | -369 M | -362 M | -355 M | -345 M | -334 M | -315 M | -295 M | -279 M | -248 M | -232 M | -223 M | -171 M | -171 M | -171 M | -171 M | -153 M | 1.15 M | 1.15 M | 1.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.15 B | 2.27 B | 708 M | 2.23 B | 1.88 B | 892 M | 441 M | 602 M | 480 M | 448 M | 366 M | 414 M | 390 M | 376 M | 366 M | 383 M | 380 M | 382 M | 421 M | 420 M | 348 M | 346 M | 119 M | 119 M | 119 M | 119 M | 72.1 M | 205 M | 205 M | 205 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
221 M | 222 M | 47.6 M | 346 M | 1.12 B | 274 M | 72.6 M | 166 M | 129 M | 105 M | 28.4 M | 58 M | 65.4 M | 48.7 M | 46.8 M | 58 M | 55 M | 48.3 M | 71.8 M | 64.8 M | 107 M | 88.2 M | 28.4 M | 27.3 M | 27.3 M | 27.3 M | 22.6 M | 1.51 M | 1.51 M | 1.51 M | 41.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
541 M | 446 M | 477 M | 581 M | 563 M | 549 M | 344 M | 440 M | 362 M | 344 M | 312 M | 329 M | 320 M | 313 M | 312 M | 311 M | 319 M | 328 M | 335 M | 355 M | 293 M | 292 M | 103 M | 103 M | 103 M | 103 M | 51.4 M | 197 M | 197 M | 197 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
477 M | 446 M | 312 M | 581 M | 563 M | 549 M | 335 M | 440 M | 362 M | 344 M | -147 M | 329 M | 320 M | 313 M | 312 M | 311 M | 319 M | 328 M | 335 M | 355 M | 293 M | 292 M | -147 M | -147 M | -147 M | -147 M | -140 M | 5 M | 5 M | 5 M | -71.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Hims & Hers Health, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Household products
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Colgate-Palmolive Company
CL
|
$ 88.5 | 1.96 % | $ 71.6 B |  USA |
 |
The Clorox Company
CLX
|
$ 89.57 | 2.06 % | $ 11.1 B | USA |
 |
Coty
COTY
|
$ 2.71 | 0.19 % | $ 2.38 B | USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.92 | 0.77 % | $ 12.3 M |  China |
 |
The Estée Lauder Companies
EL
|
$ 98.58 | 1.5 % | $ 35.7 B | USA |
 |
e.l.f. Beauty
ELF
|
$ 97.02 | 0.11 % | $ 5.65 B | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 27.03 | 0.37 % | $ 1.28 B | USA |
 |
Acme United Corporation
ACU
|
$ 60.89 | 0.28 % | $ 231 M | USA |
 |
Helen of Troy Limited
HELE
|
$ 27.49 | 2.52 % | $ 632 M |  Bermuda |
 |
Inter Parfums
IPAR
|
$ 112.19 | 0.16 % | $ 3.6 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 100.06 | 1.95 % | $ 33.2 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 6.16 | 0.81 % | $ 77.2 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.01 | 1.04 % | $ 15.2 M | USA |
 |
Nature's Sunshine Products
NATR
|
$ 13.41 | 0.89 % | $ 241 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.83 | 0.1 % | $ 238 M | USA |
 |
Newell Brands
NWL
|
$ 5.84 | 0.43 % | $ 2.44 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 146.29 | 0.7 % | $ 341 B | USA |
 |
Spectrum Brands Holdings
SPB
|
$ 85.06 | 0.6 % | $ 2.19 B | USA |
 |
United-Guardian
UG
|
$ 7.18 | 0.07 % | $ 33 M | USA |
 |
Unilever PLC
UL
|
$ 63.8 | 2.87 % | $ 139 B |  Britain |
 |
USANA Health Sciences
USNA
|
$ 15.15 | 0.87 % | $ 281 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 95.16 | 1.07 % | $ 23.1 B | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |